Latest Breaking News On - Thomas ciulla - Page 1 : comparemela.com

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference

- VRDN-001 topline clinical results for THRIVE and THRIVE-2 on track for mid-2024 and year-end 2024 in patients with active and chronic thyroid eye disease , respectively - - Subcutaneous VRDN-003.

There's help for active-duty military and veterans who see suicide as a solution, but some slip through the cracks | News

Cheryl Reppert doesn’t remember why she was awake at 1 a.m. on that August night when she received a final text message from her son, a soldier posted to Fort

Thomas Ciulla, a Leading Advisor to Global Financial Services Companies, Joins Treliant as Managing Director

/PRNewswire/ Treliant, an essential consulting partner to the global financial industry, has named Thomas Ciulla as a Managing Director in the firm s.

Thomas Ciulla, MD: Eyes with Geographic Atrophy Experience Meaningful Disease Burden

A retrospective study of nearly 19,000 eyes presented at ARVO 2023 found patients with GA lost 2 lines of vision at year 3 and are at meaningful risk of nAMD.